• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Neotract

Anonymous message board for Neotract
Replies
12
Views
8K
Pillow
Replies
41
Views
22K
anonymous
Replies
16
Views
13K
anonymous
Replies
8
Views
7K
Idiots
Replies
3
Views
4K
anonymous
Replies
3
Views
8K
Anonymous
Replies
0
Views
3K
Anonymous